Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): evolution on hypomethylating agent therapy

Leuk Res. 2011 Nov;35(11):e203-5. doi: 10.1016/j.leukres.2011.07.010. Epub 2011 Aug 9.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use*
  • Azacitidine / therapeutic use*
  • DNA Methylation / drug effects*
  • Evolution, Molecular*
  • Fatal Outcome
  • Humans
  • Leukemia, Myelomonocytic, Chronic / complications*
  • Leukemia, Myelomonocytic, Chronic / drug therapy*
  • Male
  • Syndrome
  • alpha-Thalassemia / complications*
  • alpha-Thalassemia / drug therapy*

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine